Endocrinological outcomes of pediatric craniopharyngiomas with anatomical pituitary stalk preservation: preliminary study.
We reviewed 17 pediatric craniopharyngioma patients, with a special focus on endocrinological outcomes and tumor recurrence with pituitary stalk preservation. From 1992 to February 2008, 17 patients underwent 27 surgical procedures. The male-female patient ratio was 12:5 and median patient age was 12 years (range, 4-18 years). The median follow-up period was 4.97 years (range, 1.16-15.08 years). The most frequent major presenting symptom was increased intracranial pressure (in 76.5%), followed by visual disturbance (in 23.5%). Tumors were totally removed in 70.6% of patients, subtotally removed in 23.5% and partially removed in 5.9%. The postoperative visual improvement rate was 47.6% and the postoperative visual deterioration rate was 33.3%. In 7 patients with stalk preservation, 1 received partial hormone replacement and 6 received total hormone replacement. The overall tumor recurrence and re-growth rate were 52.9%. In patients who did not receive radiotherapy immediately after their first operation, the recurrence-free survival rate differed between those with pituitary stalk preservation and those with stalk section (p = 0.04). The recurrence rate was 60% (3 of 5) in the former and 33.3% (3 of 9) in the latter. Two patients who had undergone a second operation for recurrences died. The operative morbidity rate was 23.5%. Pediatric craniopharyngiomas had high recurrence rates and low pituitary functional preservation despite anatomical stalk preservation. Therefore, maximal tumor resection might be more important than anatomical stalk preservation in pediatric craniopharyngiomas.